Moderna (MEX:MRNA) Net Interest Margin (Bank Only) %


MEX:MRNA Moderna Inc MEX:MRNA
59 GF Score
Price MXN1,425.33
GF Value MXN396.87
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Moderna Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

MEX:MRNA
59GF Score
Moderna Inc MEX:MRNA
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Moderna (MEX:MRNA) Overvalued in 2026?

Based on GuruFocus' analysis, Moderna stock appears to be overvalued. The current stock price of MXN1,425.33 is trading 259.1% above its estimated GF Value™ of MXN396.87. GuruFocus considers Moderna to be Significantly Overvalued.

Key valuation signals for MEX:MRNA:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: MXN396.87 vs. price of MXN1,425.33 (259.1% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the MEX:MRNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moderna Business Description

Address 325 Binney Street, Cambridge, MA, USA, 02142
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
59GF Score

Get the complete analysis for MEX:MRNA

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,425.33
Price
MXN396.87
GF Value